Cerebral thromboembolism is a rare complication (0.17%) during atrial fibrillation (AF) ablation, largely due to strict management of anticoagulation; inadequate anticoagulation can lead to serious issues like silent cerebral ischemia.
The study aimed to assess the effectiveness of a computerized clinical decision support system (CDSS) for precise heparin dosing during AF ablation, comparing outcomes before and after implementing the system.
The results showed that using the CDSS allowed for faster attainment of target activated clotting time (ACT) and improved stability in maintaining therapeutic levels, alongside positive feedback on the system's usability from the medical staff.